Eli Lilly & Co. v. Medtronic, Inc.
Eli Lilly & Co. v. Medtronic, Inc. | |
---|---|
| |
Argued February 26, 1990 Decided June 18, 1990 | |
Full case name | Eli Lilly & Co. v. Medtronic, Inc. |
Docket nos. | 89-243 |
Citations |
110 S. Ct. 2683; 110 L. Ed. 2d 605; 1990 U.S. LEXIS 3184; 58 U.S.L.W. 4838; 15 U.S.P.Q.2D (BNA) 1121 |
Prior history | Certiorari to the Circuit Court of Appeal for the Federal Circuit. |
Subsequent history | Rehearing Denied, August 14, 1990, Reported at 1990 U.S. LEXIS 3730. |
Holding | |
Section 271(e)(1) exempts from infringement the use of patented inventions reasonably related to the development and submission of information needed to obtain marketing approval of medical devices under the FDCA. | |
Court membership | |
| |
Case opinions | |
Majority | Scalia, joined by Rehnquist, Brennan, Marshall, Blackmun, Stevens |
Dissent | Kennedy, joined by White |
O'Connor took no part in the consideration or decision of the case. | |
Laws applied | |
35 U.S.C. § 271 |
Eli Lilly and Company v. Medtronic, Inc., 496 U.S. 661 (1990), is a United States Supreme Court case related to patent infringement in the Medical device industry. It held that 35 U.S.C. § 271(e)(1) of United States patent law exempted premarketing activity conducted to gain approval of a device under the Federal Food, Drug, and Cosmetic Act from a finding of infringement.
See also
- Medtronic, Inc. v. Lohr (1996)
- Riegel v. Medtronic, Inc. (2008)
- List of United States Supreme Court cases, volume 496
References
- 496 U.S. 661 (1990) Full text opinion from Findlaw.com
- Opinion from Cornell-LII
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.